Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (311-320 of 706) with videos related to

Pageof 71
Sort By:
Journal of the American College of Cardiology|January 5, 2005
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudyHisham Dokainish, Manu Pillai, Sabina A Murphy, et al.
The Journal of Rheumatology|April 5, 2011
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugsChristian T Ruff, David A Morrow, Peter Jarolim, et al.
Journal of the American College of Cardiology|September 11, 2004
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarctionSaihari Sadanandan, Christopher P Cannon, Kasi Chekuri, et al.
The American Journal of Cardiology|June 29, 2004
Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarctionC Michael Gibson, Brian Bigelow, David James, et al.
Circulation|September 3, 2015
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-ITErin A Bohula, Robert P Giugliano, Christopher P Cannon, et al.
The American Journal of Medicine|June 27, 2013
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosisDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Journal of the American College of Cardiology|September 14, 2010
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudyRobert F Storey, Dominick J Angiolillo, Shankar B Patil, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22Marc P Bonaca, David A Morrow, Eugene Braunwald, et al.
Clinical Orthopaedics and Related Research|December 4, 2003
Custom cross-pin fixation of 32 tumor endoprostheses stemsChristopher P Cannon, Jeffrey J Eckardt, J Michael Kabo, et al.
Clinical Cardiology|March 23, 2013
Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data RegistryOwen Mogabgab, Stephen D Wiviott, Elliot M Antman, et al.
Pageof 71

Showing results (311-320 of 706) with videos related to

Sort By:
Pageof 71
Journal of the American College of Cardiology|January 5, 2005
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudyHisham Dokainish, Manu Pillai, Sabina A Murphy, et al.
The Journal of Rheumatology|April 5, 2011
Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugsChristian T Ruff, David A Morrow, Peter Jarolim, et al.
Journal of the American College of Cardiology|September 11, 2004
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarctionSaihari Sadanandan, Christopher P Cannon, Kasi Chekuri, et al.
The American Journal of Cardiology|June 29, 2004
Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarctionC Michael Gibson, Brian Bigelow, David James, et al.
Circulation|September 3, 2015
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-ITErin A Bohula, Robert P Giugliano, Christopher P Cannon, et al.
The American Journal of Medicine|June 27, 2013
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosisDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
Journal of the American College of Cardiology|September 14, 2010
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudyRobert F Storey, Dominick J Angiolillo, Shankar B Patil, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22Marc P Bonaca, David A Morrow, Eugene Braunwald, et al.
Clinical Orthopaedics and Related Research|December 4, 2003
Custom cross-pin fixation of 32 tumor endoprostheses stemsChristopher P Cannon, Jeffrey J Eckardt, J Michael Kabo, et al.
Clinical Cardiology|March 23, 2013
Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data RegistryOwen Mogabgab, Stephen D Wiviott, Elliot M Antman, et al.
Pageof 71